{
  "docId": "019de076-8fd6-709e-8689-4f849e880c13",
  "docSlug": "045f5237a1062f1479093c113a295dbd",
  "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 29,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "propose_solution",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/25",
  "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13",
  "deckJsonHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13.json",
  "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.09,
        "y": 0.26
      },
      "kind": "framework",
      "text": "R&D Framework",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "348f4a4c-daf4-4521-9d4f-1fdb45955be4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.11,
        "y": 0.41
      },
      "kind": "list",
      "text": "Strong biological rationale; Challenging molecular design; Clear clinical pathway with early proof-of-concept; Aligns with Alkermes' expertise; Advances standard of care",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42580c39-4c1d-4254-a9b0-c180598e6e67",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.4,
        "x": 0.52,
        "y": 0.465
      },
      "kind": "list",
      "text": "Other internal neuroscience candidates: Psychiatry and neurology, Chemistry and preclinical evaluation underway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85a8e543-e08d-4834-9dc4-c60323d0d48a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.4,
        "x": 0.52,
        "y": 0.26
      },
      "kind": "list",
      "text": "Orexin 2 pathway activation: Narcolepsy, Other excessive daytime sleepiness disorders, Other neuropsychiatric disorders",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec2de872-c0af-4116-883c-d3099bec5d03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.52,
        "y": 0.67
      },
      "kind": "paragraph",
      "text": "Potential externally-sourced pipeline candidates",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb007480-52ab-48d3-abf2-ed3257ed8a98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Building a Neuroscience Development Pipeline That Leverages Alkermes' Capabilities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b5ed11f-cd20-4d4b-9934-579c48a08a3b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "c4792cbc-d444-47b6-84fa-0d4f41d7e94c",
      "evidence": "Building a Neuroscience Development Pipeline That Leverages Alkermes' Capabilities",
      "confidence": 0.7
    },
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "8b0d53b2-47cb-4c94-9f02-85267369019d",
      "evidence": "Strong biological rationale; Challenging molecular design; Clear clinical pathway with early proof-of-concept; Aligns with Alkermes' expertise; Advances standard of care",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "analytical-method",
      "slug": null,
      "matchId": "2eacd427-c2f2-49fa-b6d9-f1ebfd41f79e",
      "evidence": "The slide presents a structured set of criteria (R&D Framework) applied to categorize and evaluate pipeline candidates.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 25,
      "from": 20,
      "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Solution",
      "beatSlug": null,
      "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 25,
      "from": 16,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc",
      "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.",
      "position": 0,
      "objective": "What if Alkermes doesn't address orexin dysfunction?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}